Key result
Higher IDL cholesterol and LDL-α-tocopherol levels are linked to lower eGFR in type 2 diabetes.
Its licence doesn't allow us to show a copy here.
Why the study?
Patients with type 2 diabetes commonly exhibit atherogenic dyslipidemia and oxidative stress that may contribute to diabetic kidney disease progression, but associations of IDL cholesterol and LDL α-tocopherol with renal dysfunction are unclear.
Cross-Sectional (n=188)
In patients with T2DM, declining renal function is associated with atherogenic IDL accumulation and increased LDL α-tocopherol content, suggesting altered lipoprotein metabolism.
AIMS Patients with type 2 diabetes mellitus (T2DM) commonly exhibit atherogenic dyslipidemia and increased oxidative stress, which may contribute to the development and progression of diabetic kidney disease (DKD). We investigated the associations of intermediate-density lipoprotein cholesterol (IDL-C) and α-tocopherol in low-density lipoprotein (LDL-α-tocopherol) with renal dysfunction in T2DM. METHODS A total of 188 outpatients with T2DM were categorized into tertiles according to estimated glomerular filtration rate (eGFR). Lipoprotein fractions (HDL-, LDL-, IDL-, and VLDL-cholesterol) and LDL-α-tocopherol content were quantified using anion-exchange high-performance liquid chromatography. Arterial stiffness was assessed by brachial-ankle pulse wave velocity. Multivariable analyses were performed to evaluate associations between eGFR, lipoprotein parameters, and lipid-lowering therapy. RESULTS Declining eGFR was associated with longer diabetes duration and increased arterial stiffness. IDL-C levels and the LDL-α-tocopherol/LDL-C ratio increased significantly across decreasing eGFR tertiles, whereas LDL-C levels showed a decreasing trend. eGFR was independently and inversely correlated with IDL-C and the LDL-α-tocopherol/LDL-C ratio. Statin or fibrate therapy was associated with lower IDL-C levels and higher LDL-α-tocopherol/LDL-C ratios. CONCLUSIONS In patients with T2DM, declining DKD is associated with atherogenic IDL accumulation and increased LDL α-tocopherol content, suggesting altered lipoprotein metabolism that may influence LDL oxidation and cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Hirowatari et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (n=188). IDL cholesterol and LDL α-tocopherol was evaluated on Estimated glomerular filtration rate (eGFR). Higher IDL cholesterol and LDL-α-tocopherol/LDL-C ratios were independently and inversely correlated with estimated glomerular filtration rate in patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: